Physician profile
Mohanjit S Brar
NPI 1386665040
$75,853.50
in general payments reported to CMS, 2019-2025
39 companies · $5,243 in 2025
The $5,243 reported for 2025 was more than what 83% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,868 · 2020: $7,912 · 2021: $20K · 2022: $26K · 2023: $5,880 · 2024: $7,726 · 2025: $5,243.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Consulting Fee: $4,000 · Travel and Lodging: $3,741 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $300 · Education: $16.03.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,791.79 |
| Consulting Fee | $4,000.00 |
| Travel and Lodging | $3,740.92 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $300.00 |
| Education | $16.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $47,316.76 | 2019-2024 | Xarelto |
| Abbott Laboratories | $6,140.16 | 2019-2025 | Triclip, Supera, Mitraclip |
| Magenta Medical INC | $4,723.07 | 2024 | |
| Abiomed | $3,419.08 | 2019-2025 | Impella |
| Edwards Lifesciences Corporation | $2,993.94 | 2019-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Inari Medical, INC. | $2,299.80 | 2022-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Boston Scientific Corporation | $2,272.18 | 2019-2025 | Avvigo Guidance System, Mamba, General - Stents |
| Medtronic, INC. | $1,787.59 | 2021-2025 | Corevalve Evolut R, Ffrangio |
| Cardiovascular Systems INC. | $1,444.96 | 2019-2021 | |
| Intuitive Surgical, INC. | $394.18 | 2025 | |
| Penumbra, INC. | $350.44 | 2020-2025 | Penumbra System |
| Novartis Pharmaceuticals Corporation | $334.16 | 2019-2025 | |
| Stryker Corporation | $304.36 | 2025 | Flowtriever, Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Angiodynamics, INC. | $254.24 | 2021-2023 | Angiovac |
| Astrazeneca Pharmaceuticals LP | $242.98 | 2019-2022 |
Show all 38 companies
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohanjit Brar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.